Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

E Protein Domain III Determinants of Yellow Fever Virus 17D Vaccine Strain Enhance Binding to Glycosaminoglycans, Impede Virus Spread, and Attenuate Virulence

10 Apr 2008

Abstract excerpt

The yellow fever virus (YFV) 17D strain is one of the most effective live vaccines for human use, but the in vivo mechanisms for virulence attenuation of the vaccine and the corresponding molecular determinants remain elusive. The vaccine differs phenotypically from wild-type YFV by the loss of viscerotropism, despite replicative fitness in cell culture, and genetically by 20 amino acid changes predominantly...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Mosquito-borne diseases and control
Share to Viral Infections and Outbreaks Research
Share to Viral Infections and Vectors

Methodology Data sources Editorial policy Privacy Delete account & data About Contact Helena Bioinformatics

Source

Identifiers

PMID: 18400851
DOI: 10.1128/jvi.02509-07

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 25 Oct 2026.

Related research

Semantic proximity does not establish scientific evidence. Graph snapshot: 2026-09-29.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

E Protein Domain III Determinants of Yellow Fever Virus 17D Vaccine Strain Enhance Binding to Glycosaminoglycans, Impede Virus Spread, and Attenuate VirulencePMID 18400851Read ↗

Two mutations in NS2B are responsible for attenuation of the yellow fever virus (YFV) vaccine strain 17D.Semantic proximity Read ↗

Vaccine and Wild-Type Strains of Yellow Fever Virus Engage Distinct Entry Mechanisms and Differentially Stimulate Antiviral Immune ResponsesSemantic proximity Read ↗

Impact of yellow fever virus envelope protein on wild-type and vaccine epitopes and tissue tropismSemantic proximity Read ↗

Mutation in a 17D-204 Vaccine Substrain-Specific Envelope Protein Epitope Alters the Pathogenesis of Yellow Fever Virus in MiceSemantic proximity Read ↗

A single residue in domain II of envelope protein of yellow fever virus is critical for neutralization sensitivity.Semantic proximity Read ↗

The yellow fever 17D virus as a platform for new live attenuated vaccinesSemantic proximity Read ↗

The 17D-204 and 17DD yellow fever vaccines: an overview of major similarities and subtle differencesSemantic proximity Read ↗

Next generation live-attenuated yellow fever vaccine candidate: Safety and immuno-efficacy in small animal modelsSemantic proximity Read ↗

Yellow fever 17D vaccine virus isolated from healthy vaccinees accumulates very few mutations.Semantic proximity Read ↗

Antigenic variants of yellow fever virus with an altered neurovirulence phenotype in mice.Semantic proximity Read ↗

Yellow Fever: Integrating Current Knowledge with Technological Innovations to Identify Strategies for Controlling a Re-Emerging VirusSemantic proximity Read ↗

Comparison of the genomes of the wild-type French viscerotropic strain of yellow fever virus with its vaccine derivative French neurotropic vaccineSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.